Shema Oral Liquid Ameliorates the Severity of LPS-Induced COPD via Regulating DNMT1

• Main Authors: Fangbo Zhang (Author), Feifei Guo (Author), Yang Liu (Author), Yi Zhang (Author), Defeng Li (Author), Hongjun Yang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Chronic obstructive pulmonary disease (COPD) is the most common respiratory disease with high morbidity and mortality. Shema oral liquid (Shema) is a traditional Chinese medicine (TCM) approved for the treatment of respiratory diseases. Clinical applications have shown that Shema has ant...